Skip to main content
logo
ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
0.8300
+0.0343 (4.31%)
At close: Aug 28, 2026, 4:00 PM EDT
0.8700
+0.0400 (4.82%)
After-hours: Aug 28, 2026, 7:30 PM EDT

ABVC BioPharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--0.510.150.970.36
Revenue Growth
--234.31%-84.28%172.57%-26.34%
Gross Profit
--0.51-0.150.680.35
Operating Income
-6.52-7.15-4.71-6.77-15.11-11.71
Net Income
-7.11-7.91-4.9-7.79-16.42-12.84
Earnings Per Share
-0.29-0.39-0.42-1.80-5.19-5.12
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.090.750.310.140.165.94
Total Debt
2.893.473.22.773.413.34
Net Cash (Debt)
-2.79-2.73-2.88-2.63-3.252.6
Net Cash Growth
------
Net Cash Per Share
-0.11-0.14-0.25-0.61-1.031.04

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.69-2.99-1.81-4.19-7.4-7.6
Capital Expenditures
----0.02-0.12-0.02
Free Cash Flow
-2.69-2.99-1.81-4.21-7.52-7.62
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--99.85%-98.15%70.47%98.57%
Operating Margin
---923.34%-4439.24%-1558.54%-3290.07%
Pretax Margin
---1053.71%-5264.61%-1599.80%-3150.91%
Profit Margin
---962.12%-5109.26%-1693.50%-3608.47%
FCF Margin
---355.02%-2760.64%-775.23%-2140.33%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--14.1858.7220.85269.96